Skip to content

Clinical trials

Osteoporosis, Postmenopausal trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis, Postmenopausal Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20043
20051
20062
20081
20123
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Amgen3
Hoffmann-La Roche3
Sanofi2
Warner Chilcott2
Australian Catholic University1
Bespoke Clinical Research1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis, Postmenopausal17
Osteoporosis5
Bone Diseases2
Bone Diseases, Metabolic2
Musculoskeletal Diseases2
Back Pain1
Cardiovascular Diseases1
Cognitive Dysfunction1
Dementia1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.